MilliporeSigma Helps Accelerate Global Access to Affordable Vaccines Collaboration with Oxford University to develop cost-effective vaccine manufacturing processes, accelerate vaccine availability Company also planning new vaccine manufacturing facility in Ghana to help country and region address health challenges
This partnership, as well as plans to develop a vaccine manufacturing facility in Ghana, further the company's commitment to improving global health by making vaccines more affordable and available.